The NHSL3 Knockout SK-HEP-1 Polyclonal Cells are a heterogeneous population of CRISPR/Cas9-edited cells with targeted disruptions in the NHSL3 gene. This polyclonal knockout pool provides a versatile loss-of-function model without clonal selection, preserving biological variability. Generated using CRISPR/Cas9-mediated gene disruption, it offers a robust system to interrogate NHSL3 function in liver adenocarcinoma.
SK-HEP-1 is a human liver adenocarcinoma cell line isolated from ascites of a hepatocellular carcinoma patient. It serves as a widely used in vitro model for liver cancer research, recapitulating malignant hepatocyte features and enabling study of tumor cell behavior, including proliferation, migration, and invasion. Its ascites-derived origin is particularly relevant for investigating metastatic dissemination, a common manifestation of advanced abdominal cancers.
NHSL3 encodes a protein with an NHS-like domain, evolutionarily conserved and implicated in actin cytoskeleton regulation and cell adhesion. Although its signaling network is poorly defined, NHSL3 is predicted to interact with actin, directly modulating cytoskeletal dynamics. Through actin interaction, NHSL3 may contribute to focal adhesion assembly and remodeling, influencing cell morphology and motility. Actin remodeling is critical for cancer cell migration, positioning NHSL3 as a candidate mediator of invasive behavior. Upstream regulators and downstream effectors remain unknown, making this knockout model essential for elucidating its functions.
In SK-HEP-1 liver adenocarcinoma cells, NHSL3 knockout likely perturbs cytoskeletal organization and adhesion, altering migratory and invasive capabilities. As hepatocellular carcinoma frequently metastasizes, understanding adhesion genes like NHSL3 is critical. This polyclonal model enables study of heterogeneous responses to NHSL3 loss, mirroring tumor genetic diversity. Researchers can thus investigate how NHSL3 loss impacts actin-based structures and adhesion dynamics in liver cancer, yielding insights into metastasis mechanisms.
This NHSL3 polyclonal knockout product suits diverse experimental approaches. Knockout confirmation can be done via western blotting and RT-qPCR. Functional studies may assess cytoskeletal integrity by immunofluorescence for actin and evaluate morphology changes. Migration and invasion assays (Boyden chamber or wound healing) determine motility impact, while cell adhesion assays clarify substrate attachment roles. These assays enable dissection of NHSL3-mediated mechanisms in hepatocellular carcinoma. For further information, please contact Ascent Research.
